S 1803 115th Congress Senate Crime and Law Enforcement Administrative law and regulatory procedures Alternative treatments Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Health personnel Licensing and registrations Medical research Research administration and funding

MEDS Act

Introduced: September 13, 2017 See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 13, 2017

Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484)

Sep 13, 2017

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Marijuana Effective Drug Studies Act of 2017 or the MEDS Act

This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.

Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.

What's happening now September 13, 2017

Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484)

Related & companion bills 1

Bill text 1 version